TrialPLoS medicine2021

Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.

Fred C Semitala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.